Nursing home drug trends: are dementia patients getting unmonitored meds?
NCT ID NCT06095284
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how often antiepileptic drugs (AEDs) are prescribed to long-stay nursing home residents with dementia, especially before and after the COVID-19 pandemic. Researchers will analyze data from millions of residents to see if these medications are being used more, even though they are not tracked by Medicare like other psychoactive drugs. The goal is to understand prescribing patterns and any related health outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEMENTIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Virginia Commonwealth University
Richmond, Virginia, 23298, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple questionnaire empower dementia caregivers after hospital stays?
- Can a simple test predict Alzheimer's before symptoms worsen?
- Can a Voice-Based app map healthy brain aging across 80 years?
- Could sharing lived experiences ease the burden of dementia care?
- A new tool aims to shield dementia patients from neglect
- Brain scans could unlock the hidden timeline of Alzheimer's